The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease
Abstract
THE advent of pharmacologic strategies for increasing γ-chain synthesis in patients with sickle cell disease and other hemoglobinopathies1 2 3 4 5 6 7 has made it important to ascertain the benefit that may be expected from various increases in fetal hemoglobin (hemoglobin F) levels. Although the increases in hemoglobin F levels resulting from the use of drugs such as azacytidine and hydroxyurea appear to be moderate (≤20 percent hemoglobin F), the potential toxicity of these drugs is relatively high. Fortunately, in the past few years, epidemiologic analyses of the severity of sickle cell disease and studies of the biophysics of intracellular polymerization have led to . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The rate of polymerization is proportional to the intraerythrocytic concentration of HbS (to the 34th power) and inversely proportional to the concentration of fetal Hb (HbF), which both replaces HbS and interferes with HbS polymerization (7, 10, 11).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [10]
In the citing paper
“In fact, such levels, if achieved at the fetal globin genes in vivo in human sickle cell anemia patients would be sufficient to ameliorate the clinical course of their disease (see also below) (Noguchi et al., 1988; Platt et al., 1991).”
From Reactivation of developmentally silenced globin genes by forced chromatin looping (2014) · cites this paper as Noguchi et al., 1988
Citations
Cites
Serjeant, G. R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07330-3 · Cited by 762
Self-citationHydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
Platt, O. S., Orkin, S. H., Dover, G., Beardsley, G. P., Miller, B., & Nathan, D. G. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111464 · Cited by 535
5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia
Ley, T. J., DeSimone, J., Anagnou, N. P., Keller, G. H., Humphries, R. K., Turner, P. H., Young, N. S., Heller, P., & Nienhuis, A. W. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212093072401 · Cited by 490
5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons.
DeSimone, J., Heller, P., Hall, L., & Zwiers, D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.14.4428 · Cited by 384
DNA sequence variation associated with elevated fetal G gamma globin production
Gilman, J., & Huisman, T. (1985) · Blood · doi:10.1182/blood.v66.4.783.783 · Cited by 373
Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?
Powars, D., Weiss, J., Chan, L., & Schroeder, W. (1984) · Blood · doi:10.1182/blood.v63.4.921.921 · Cited by 314
Natural History of Sickle Cell Anemia in Saudi Arabs: A Study of 270 Subjects
PERRINE, R. P., PEMBREY, M. E., JOHN, P., PERRINE, S., & SHOUP, F. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-88-1-1 · Cited by 284
Charache, S., Dover, G., Smith, K., Talbot, C. C., Moyer, M., & Boyer, S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4842 · Cited by 275
Ley, T., DeSimone, J., Noguchi, C., Turner, P., Schechter, A., Heller, P., & Nienhuis, A. (1983) · Blood · doi:10.1182/blood.v62.2.370.370 · Cited by 252
Self-citationLabie, D., Pagnier, J., Lapoumeroulie, C., Rouabhi, F., Dunda-Belkhodja, O., Chardin, P., Beldjord, C., Wajcman, H., Fabry, M. E., & Nagel, R. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2111 · Cited by 234
Research works printed but not linked: 3
- Pembrey, 1980, Am J Hum Genet, 32, 26
- Schechter AN, Noguchi CT, Rodgers GP. Sickle cell anemia. In: Stamatoyannopoulos G, Nienhuis AW, Leder P, Majerus P, eds. Molecular basis of blood diseases. Philadelphia: W.B. Saunders, 1987:179–218.
- Sumoza, 1986, Blood, 68, 67a
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Self-citationPathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Prediction of Adverse Outcomes in Children with Sickle Cell Disease
Miller, S. T., Sleeper, L. A., Pegelow, C. H., Enos, L. E., Wang, W. C., Weiner, S. J., Wethers, D. L., Smith, J., & Kinney, T. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420203 · Cited by 508
Metadata
- Authors
- Noguchi, C. T., Rodgers, G. P., Serjeant, G., & Schechter, A. N.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1988-01-14
- Volume
- 318
- Issue
- 2
- Pages
- 96-99
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2005752061
- Cited by
- 222
- References
- 35
- Citations by year
- 2025: 5 · 2024: 6 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 12 · 2015: 4 · 2014: 5 · 2013: 2 · 2012: 6
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, fetal hemoglobin, hydroxyurea, azacitidine, hemoglobinopathies, disease severity
- MeSH terms
- Anemia, Sickle Cell, Azacitidine, Fetal Hemoglobin, Humans, Hydroxyurea, Polymers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease. https://app.cochat.ai/papers/10.1056/nejm198801143180207
- The paper
- Noguchi, C. T., Rodgers, G. P., Serjeant, G., & Schechter, A. N. (1988). Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease. New England Journal of Medicine. https://doi.org/10.1056/nejm198801143180207
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.